APA

Ursini C. L., Omodeo Salè E., Fresegna A. M., Ciervo A., Jemos C., Maiello R., Buresti G., Colosio C., Rubino F. M., Mandić-Rajčević S., Chiarella P., Carbonari D., Delrio P., Maiolino P., Marchetti P., Boccia R., Iavicoli S. & Cavallo D. (20191021). Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. : Toxicology letters.

Chicago

Ursini C L, Omodeo Salè E, Fresegna A M, Ciervo A, Jemos C, Maiello R, Buresti G, Colosio C, Rubino F M, Mandić-Rajčević Stefan, Chiarella P, Carbonari D, Delrio P, Maiolino P, Marchetti P, Boccia R, Iavicoli S and Cavallo D. 20191021. Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. : Toxicology letters.

Harvard

Ursini C. L., Omodeo Salè E., Fresegna A. M., Ciervo A., Jemos C., Maiello R., Buresti G., Colosio C., Rubino F. M., Mandić-Rajčević S., Chiarella P., Carbonari D., Delrio P., Maiolino P., Marchetti P., Boccia R., Iavicoli S. and Cavallo D. (20191021). Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. : Toxicology letters.

MLA

Ursini C L, Omodeo Salè E, Fresegna A M, Ciervo A, Jemos C, Maiello R, Buresti G, Colosio C, Rubino F M, Mandić-Rajčević Stefan, Chiarella P, Carbonari D, Delrio P, Maiolino P, Marchetti P, Boccia R, Iavicoli S and Cavallo D. Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker. : Toxicology letters. 20191021.